Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

PaperCitations, authors & open-access status

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,333 citations, 2017 year and bronze oa status.

1,333
Citations
2017
Year
bronze
OA Status

Related on ScholarIQ

Marcus Flather
Author
Renato D. Lópes
Author
Henry Krum
Author
José Carlos Nicolau
Author
Helen M. Colhoun
Author
The Lancet
Journal
470M+ articles · free account